Gastric cancer-derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier

FEBS Lett. 2017 Jul;591(14):2167-2179. doi: 10.1002/1873-3468.12722. Epub 2017 Jul 10.

Abstract

An intact mesothelium serves as a protective barrier to inhibit peritoneal carcinomatosis. Cancer-derived exosomes can mediate directional tumor metastasis; however, little is known about whether gastric cancer-derived exosomes will destroy the mesothelial barrier and promote peritoneal dissemination. Here, we demonstrate that gastric cancer-derived exosomes facilitate peritoneal metastasis by causing mesothelial barrier disruption and peritoneal fibrosis. Injury of peritoneal mesothelial cells elicited by gastric cancer-derived exosomes is through concurrent apoptosis and mesothelial-to-mesenchymal transition (MMT). Additionally, upregulation of p-ERK in peritoneal mesothelial cells is primarily responsible for the MMT while contributing little to apoptosis. Together, these data support the concept that exosomes play a crucial role in remodeling the premetastatic microenvironment and identify a novel mechanism for peritoneal metastasis of gastric carcinoma.

Keywords: exosome; gastric cancer; mesothelial barrier destruction; peritoneal mesothelial cell; peritoneal metastasis.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Cell Line, Tumor
  • Epithelium / pathology*
  • Exosomes / pathology*
  • Humans
  • MAP Kinase Signaling System
  • Mesoderm / pathology
  • Peritoneal Neoplasms / secondary*
  • Stomach Neoplasms / pathology*